EODData

MEMBERSHIP REGISTER LOG IN

FRA, PBDA: PROTALIX BIOTHERAP.DL-01

14 Aug 2026
LAST:

1.916

CHANGE:
 0.11		OPEN:
2.030		HIGH:
2.030		ASK:
0.000		VOLUME:
0
CHG(%):
5.38		PREV:
2.025		LOW:
1.916		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
14 Aug 262.0302.0301.9161.9160
13 Aug 262.2302.2302.0252.0250
12 Aug 262.0652.3002.0652.2550
07 Aug 262.0752.1052.0702.1050
06 Aug 262.0802.1302.0802.0950
05 Aug 262.0252.1002.0252.1000
03 Aug 262.0302.0751.9961.9960
31 Jul 261.9422.0351.9422.0350
30 Jul 261.9501.9681.9401.9500
29 Jul 262.0052.0851.9641.9720

PROFILE

Name:PROTALIX BIOTHERAP.DL-01
About:Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system. The company offers Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. It is also developing PRX-115, a plant cell expressed recombinant PEGylated Uricase, which is in Phase 2 trial for the treatment of gout; and PRX-119, a plant cell expressed PEGylated recombinant human DNase I product candidate for the treatment of neutrophil extracellular traps diseases. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz; and Chiesi Farmaceutici S.p.A. It operates in the United States, Australia, Canada, Israel, Brazil, Russia, and Turkey. The company is headquartered in Hackensack. New Jersey.
Sector:Healthcare
Industry:Biotechnology
Address:2 University Plaza, Hackensack, NJ, United States, 07601
Website:https://www.protalix.com
ISIN:US74365A3095
LEI:549300SDVB3GP4XDFM60

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:12.09 
Forward P/E:51.38 
PEG Ratio:-0.02 
Price to Sales:2.17 
Price to Book:2.80 
Profit Margin:0.20 
Operating Margin:0.63 
Return on Assets:0.14 
Return on Equity:0.27 
Revenue:66.97M 
EBITDA:18.69M 
Shares:79.73M 
Market Cap:152.77M 

TECHNICAL INDICATORS

MA5:2.088.5%
MA10:2.046.7%
MA20:2.056.8%
MA50:1.941.2%
MA100:1.891.6%
MA200:1.881.7%
RSI14:41.98
WPR14:-100.00 
MTM14:-0.14
ROC14:-0.07 
ATR:0.09 
Week High:2.3020.0%
Week Low:1.920.0%
Month High:2.3020.0%
Month Low:1.921.7%
Year High:2.6638.8%
Year Low:1.2355.8%

RECENT SPLITS

Date Ratio
20 Dec 20191-10